Doximity (NYSE:DOCS) CAO Sells 2,077 Shares of Stock

Doximity, Inc. (NYSE:DOCS) CAO Siddharth Sitaram sold 2,077 shares of the firm’s stock in a transaction that occurred on Tuesday, September 15th. The stock was sold at an average price of $26.02, for a total transaction of $54,043.54. Following the sale, the chief accounting officer owned 96,045 shares of the company’s stock, valued at $2,499,090.90. This trade represents a 2.12% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Siddharth Sitaram also recently made the following trade(s):

• On Thursday, August 13th, Siddharth Sitaram sold 1,770 shares of Doximity stock. The stock was sold at an average price of $24.94, for a total value of $44,143.80.

Doximity Stock Up 0.4%

Shares of Doximity stock traded up $0.10 on Wednesday, hitting $25.91. The stock had a trading volume of 2,282,684 shares, compared to its average volume of 4,075,272. Doximity, Inc. has a twelve month low of $17.15 and a twelve month high of $76.51. The business’s 50 day moving average is $23.82 and its two-hundred day moving average is $23.11. The stock has a market cap of $4.62 billion, a price-to-earnings ratio of 30.48, a price-to-earnings-growth ratio of 20.64 and a beta of 1.25.

Doximity (NYSE:DOCS) last announced its earnings results on Thursday, August 6th. The company reported $0.29 earnings per share for the quarter, topping analysts’ consensus estimates of $0.16 by $0.13. The company had revenue of $156.62 million for the quarter. Doximity had a return on equity of 18.06% and a net margin of 25.48%.Doximity’s revenue for the quarter was up 7.3% on a year-over-year basis. During the same quarter last year, the business posted $0.36 EPS. As a group, equities analysts predict that Doximity, Inc. will post 0.74 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Doximity

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Capital World Investors grew its holdings in shares of Doximity by 5.1% during the 4th quarter. Capital World Investors now owns 5,654,875 shares of the company’s stock worth $250,398,000 after purchasing an additional 273,444 shares in the last quarter. Carmignac Gestion lifted its position in Doximity by 127.8% during the first quarter. Carmignac Gestion now owns 4,311,997 shares of the company’s stock worth $100,480,000 after purchasing an additional 2,418,971 shares during the period. Renaissance Technologies LLC lifted its position in Doximity by 29.4% during the first quarter. Renaissance Technologies LLC now owns 3,059,749 shares of the company’s stock worth $71,292,000 after purchasing an additional 694,300 shares during the period. Wellington Management Group LLP grew its stake in Doximity by 24.7% during the second quarter. Wellington Management Group LLP now owns 3,135,113 shares of the company’s stock worth $65,022,000 after buying an additional 621,464 shares in the last quarter. Finally, SG Americas Securities LLC increased its holdings in Doximity by 3,403.2% in the 1st quarter. SG Americas Securities LLC now owns 1,408,597 shares of the company’s stock valued at $32,820,000 after buying an additional 1,368,388 shares during the period. 87.19% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research firms have weighed in on DOCS. Zacks Research upgraded Doximity from a “strong sell” rating to a “hold” rating in a research report on Monday, July 13th. Citigroup downgraded shares of Doximity to an “underperform” rating in a research note on Monday, June 29th. Freedom Capmkts lowered shares of Doximity from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, September 8th. Weiss Ratings upgraded shares of Doximity from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday. Finally, Wolfe Research upgraded shares of Doximity to an “outperform” rating in a research note on Thursday, August 13th. Two research analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating, fourteen have issued a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $32.18.

Doximity Company Profile

Doximity, Inc operates a digital platform for U.S. medical professionals. Its network enables physicians and other healthcare providers to communicate, collaborate, access medical news and research, maintain professional profiles, and connect with colleagues and patients.

The company offers a range of tools for healthcare organizations and professionals, including telehealth services, digital faxing, scheduling and communication products, and solutions for recruiting and marketing. Doximity also provides pharmaceutical and healthcare companies with digital engagement services designed to reach medical professionals through its platform.

Founded in 2010, Doximity is headquartered in San Francisco and primarily serves the United States healthcare market.